Quantitative Structure Activity Relationships in Computer Aided Drug Design: A Review

  • Divya Niranjan
  • Simran Gill
  • Deepali Shrivastava
  • Aakash Jain
  • Om Prakash Agrawal


The process of processing a drug and reaching to the market consists of various steps. In the early times of Drug Discovery, researchers faced with little or no Structure Activity Relationships information regarding any chemical moiety. Computer Aided Drug Designing (CADD) is a discipline allowing various aspects of research to merge together and stimulate each other. CADD acts as a tunnel in Drug Discovery and accelerates finding new lead compounds. The theoretical basis of CADD involves quantum mechanics and molecular modelling studies like Structure-based design, Ligand-based design, database searching and binding affinity. QSAR is structural descriptors of chemical compound to its biological activity. It is very important to find out relationships between molecular structure and useful properties and so Drug Discovery and Development get more complex. But automation of chemical synthesis and pharmacological screening provides a vast amount of experimental data.

Keywords: QSAR, Drug Design, CADD, Descriptor.


Download data is not yet available.


1. Albert A, Selective toxicity, Chapman and Hall London, 7th edition, 1985, 324-354.
2. Augen, J. Drug Discovery Today, 2002; 7:315.
3. Baldi A, Computational Approaches for Drug and Discovery. An Overview, College of Pharmacy, Dr.Shri R.M.S Institute of Science and Technology, Bhanpura, Dis. Mandsaur (M.P).
4. Basak S.C., Chemobioinformatics : the advancing frontier of Computer Aided Drug Design in the post genomic era current Computer Aided Drug Design 2012; 8:1-2.
5. B. Hamman, Recurrent Networks for Structural Data. A Unifying Approach and its Properties, Cognitive Systems Research, 2002; 3:145 -185.
6. Borchardt , JK, The Alchemist 6 December 2001.
7. Enyedy IJ, Egan WJ, can we use docking and scoring for hit-to-lead optimization? J. Computer Aided Molecuar Design 2008; 22:161-168.
8. Free SM and Wilson, J.W, J.Med.Chem., 1964; 7:395.
9. Fujita T, Junkichi I, Hansch C, J. Amchan, Soc. 1964; 86:5175.
10. Guida, WC Current Structure Biology, 1994, 4, 777.
11. Hammett L.P,Chem Rev. 1935; 17:125.
12. Hansch C, LeoA, Substituent Constants for Correlation Analysis in Chemistry and Biology join Wiley, 1979, New York.
13. Hansch C, Muer RM, Fujita T, Maloney P, Geiger E, Streich M, J. Amchem. Soc. 1963; 85:2817.
14. http://www.biophy.mpg.de/en/theoretical.biophysics/computaational-drug-design.html
15. Ivanov AS, Veselovsky AV, Strategy of Computer Aided Drug Design “Current Drug Targets Infectious Disorders, 2003, Page No.33-40.
16. Kubinyi. H,Prog. Drug Res, 1979; 23:97.
17. LeoAJ, Weigner D, CROGP, Pomona College Medicinal Chemistry Project, Claremont, 1987, California.
18. Lohse, M.J Trends Pharmacology Science 1998; 19:198.
19. Malik Jitender K, SoniHimesh, Singhai AK, PandeyHansh QSAR. Application in Drug Design. International Journal of Pharmaceutical Research and Allied Sciences.
20. Mccall J. J. Chromatography, 1975; 1:113.
21. Meyer H. Arch Exp. Pathol, Pharmacel, 1899; 42:109.
22. NysBG, Rekker RF,Chim. Therap, 1963; 8:521.
23. OkselCeyda, Wang Xuez, Quantitative Structure Activity Relationship models, University of Leeds (2013).
24. Overton E, Studies Uber diesNarkox, Fischer, Jena, 1901, 45.
25. Swain CG, CuptonEC, JAmchemSec, 1968, 90, 4328.
26. Takagi T, Kimera A, Da YZ, Nakai H, Flujiwara H, Anal. Sci. 1992, 8,761.
27. Tanaka A, Nakamura K, Nakanishi I, Fujwara H, J. Med Chem, 37,1994, 4563.
28. Tomlinson E Chem. Rav.1935; 17:125
29. VermaJitender, Coutinho Evans, Khedka Vijay M, 3D QSAR in Drug Design Current Topics in Medicinal Chemistry, November 2009,95-115.
30. Winkler David A, The role of Quantitative Structure Activity Relationships in Bio-molecular Discovery, 22nd November 2001.
1 Views | 5 Downloads
How to Cite
Niranjan, D., Gill, S., Shrivastava, D., Jain, A., & Agrawal, O. P. (2019). Quantitative Structure Activity Relationships in Computer Aided Drug Design: A Review. Journal of Drug Delivery and Therapeutics, 9(3), 645-649. https://doi.org/10.22270/jddt.v9i3.2662